110379 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV Use of virus, viral particle or viral elements as a vector
Sub-classes:ERRalpha GENE KNOCKOUT ERYTHROID PROGENITOR CELLS AND METHODS OF ERYTHROID DIFFERENTIATION THEREOF
#2VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME
#3METHODS FOR TRANSDUCING IMMUNE CELLS
#4COMPOSITIONS AND METHODS FOR GENERATING A PERSISTING POPULATION OF T CELLS USEFUL FOR THE TREATMENT OF CANCER
#5METHODS FOR THE PURIFICATION OF VIRAL VECTORS
#6HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDENT CANCERS
#7VIRAL VECTORS AND PACKAGING CELL LINES
#8VIRAL VECTORS AND PACKAGING CELL LINES
#9CAR and Polyspecific Binding Molecules Targeting Solid Tumors
#10System And Methods For Producing Chimeric Antigen Receptor Cells
#11CD5 Modified Cells Comprising Chimeric Antigen Receptors (CARs) for Treatment of Solid Tumors
#12Transgenic Immune Cell, Construction Method Therefor and Use Thereof
#13HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#14COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF
#15Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy
#16SELF-POLARIZING IMMUNE CELLS
#17HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#18NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES
#19DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION
#20PRE-IMMUNIZATION AND IMMUNOTHERAPY
#21CHIMERIC ANTIGEN RECEPTORS AND MODIFIED CELLS COMPRISING THE SAME
#22CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY
#23POLYPEPTIDE FOR RESISTING NOVEL CORONAVIRUS AND APPLICATION THEREOF
#24NOVEL POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES AND USE FOR SAME
#25END-TO-END CELL THERAPY AUTOMATION
#26CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA AND USE THEREOF
#27METHODS AND COMPOSITIONS FOR CRISPR/CAS9 GUIDE RNA EFFICIENCY AND SPECIFICITY AGAINST GENETICALLY DIVERSE HIV-1 ISOLATES
#28METHODS FOR PRODUCING CLINICAL-GRADE LENTIVIRAL VECTOR
#29NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE
#30ENGINEERED HEPATITIS B VIRUS NEUTRALIZING ANTIBODIES AND USES THEREOF
#31ULTRA-SENSITIVE STEP-FUNCTION OPSIN FOR MINIMALLY INVASIVE OPTOGENETIC STIMULATION
#32TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION
#33GENE EDITING METHODS AND COMPOSITIONS FOR ELIMINATING RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY
#34NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF
#35IMPROVED LENTIVIRAL EXPRESSION VECTOR, CONSTRUCTION METHOD FOR SAME, AND APPLICATIONS THEREOF
#36ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
#37Delivery of card protein as therapy for ocular inflammation
#38COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
#39METHODS AND CONSTRUCTS FOR TRANSIENT PRODUCTION OF LENTIVIRAL VECTOR
#40Compositions and methods for treatment of GCase related disease states
#41IMPROVED IN VIVO REPROGRAMMING SYSTEM AND CELL CONVERSION METHOD USING SAME
#42End-to-end cell therapy automation
#43End-to-end cell therapy automation
#44END-TO-END CELL THERAPY AUTOMATION
#45ANTI-ROBO1 CAR-T CELL, AND PREPARATION AND APPLICATION THEREOF
#46METHODS FOR TRANSDUCING IMMUNE CELLS
#47METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE
#48Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
#49Methods for the purification of viral vectors
#50SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#51Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#52Methods of improving vector transduction efficiency into T lymphocytes
#53Compositions and methods for hemoglobin production
#54Chimeric receptors to DLL3 and methods of use thereof
#55METHOD FOR PRODUCING T CELLS MODIFIED BY CHIMERIC ANTIGEN RECEPTOR
#56Viral vectors and packaging cell lines
#57Compositions and methods for treating cancer with anti-CD123 immunotherapy
#58Human mesothelin chimeric antigen receptors and uses thereof
#59Compositions and methods for treatment of GCASE related disease states
#60Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#61Compositions and methods for the treatment of myotonic dystrophy
#62SELF-LIMITING CAS9 CIRCUITRY FOR ENHANCED SAFETY (SLICES) PLASMID AND LENTIVIRAL SYSTEM THEREOF
#63End-to-end cell therapy automation
#64Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#65Human neural precursor cells with inducible STIM1 knockdown
#66Compositions and methods for treating cancer with anti-CD123 immunotherapy
#67ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#68PRODUCTION OF ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY
#69IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINE LEVELS WITH THE LONG NON-CODING RNA UMLILO
#70Packaging cell for making a pseudotyped lentivirus
#71VCN enhancer compositions and methods of using the same
#72TIM3 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#73Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy
#74T cell compositions
#75End-to-end cell therapy automation
#76Anti-ROBO1 CAR-T cell, and preparation and application thereof
#77Nipah virus envelope pseudotyped lentiviruses and methods of their use
#78Large commercial scale lentiviral vector production system and vectors produced thereby
#79Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
#80Methods and compositions for sustained immunotherapy
#81Method for converting mesenchymal stem cells into endothelial cells by using specific transcription factors
#82HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancers
#83OPTICALLY-BASED STIMULATION OF TARGET CELLS AND MODIFICATIONS THERETO
#84Reprogramming-based models of neurodevelopmental disorders and uses thereof
#85Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
#86Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#87Compositions and methods for improving viral vector efficiency
#88Methods of generating neural stem cells
#89Compositions and methods for treatment of Gcase related disease states
#90Lentiviral protein delivery system for RNA-guided genome editing
#91Methods of delivering a pseudotyped lentivirus
#92HIV pre-immunization and immunotherapy
#93Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
#94Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction
#95Methods of producing modified natural killer cells and methods of use
#96IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINE LEVELS WITH THE LONG NON-CODING RNA UMLILO
#97INDUCED PLURIPOTENT STEM CELLS
#98METHODS FOR TREATING TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA WITH APOLIPOPROTEIN D
#99Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
#100Methods of improving vector transduction efficiency into T lymphocytes
#101Optically-based stimulation of target cells and modifications thereto
#102Thymidylate kinase fusions and uses thereof
#103Optically-based stimulation of target cells and modifications thereto
#104Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#105Pharmaceutical composition and method for reducing scar formation
#106Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#107Human mesothelin chimeric antigen receptors and uses thereof
#108Materials and methods for treatment of pulmonary arterial hypertension
#109Delivery of card protein as therapy for occular inflammation
#110Compositions and methods for treating pancreatic cancer
#111Methods for treating tissue damage associated with ischemia with apolipoprotein D
#112Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#113Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
#114Method of stimulating an immune response using a pseudotyped lentivirus
#115Methods and compositions for sustained immunotherapy
#116Vectors for transgene expression
#117Methods of genetically modifying animal cells
#118Nipah virus envelope pseudotyped lentiviruses and methods of their use
#119Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs
#120SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION
#121Mammalian Cell Culture System for Large-Scale Expression of Recombinant Proteins
#122Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
#123LARGE COMMERCIAL SCALE LENTIVIRAL VECTOR PRODUCTION SYSTEM AND VECTORS PRODUCED THEREBY
#124Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming
#125Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
#126Lentiviral vectors containing an MHC class I promoter
#127Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs
#128Induced pluripotent stem cells
#129Targeted gene delivery to dendritic cells
#130Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#131Optically-based stimulation of target cells and modifications thereto
#132Single lentiviral vector system for induced pluripotent (iPS) stem cells derivation
#133Thymidylate kinase fusions and uses thereof
#134Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#135Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#136Targeted gene delivery for dendritic cell vaccination